Pharmaceutical drugs and biologics logistics is the logistics of pharmaceutical and biologic drugs from the manufacturer to the end-user. It includes transportation, warehousing, inventory management and other logistics functions.
The global pharmaceutical drugs and biologics logistics market was valued at $79.9 billion in 2017. North America accounted for the largest portion of the global pharmaceutical drugs and biologics logistics market at about 37.8% in 2017. The USA was the largest country in the market, accounting for 26.1% of the market in 2017.
The pharmaceutical drugs and biologics logistics market is undergoing increasing consolidation by several large pharmaceutical logistics companies acquiring smaller logistic companies to extend their geographical presence and proprietary knowledge. With an acquisition, large firms acquire new technologies and expertise, while providing the smaller vendors with adequate financial and infrastructural support.
The companies covered are Deutsche Post DHL, FedEx Corporation, UPS, Panalpina World Transport (Holding) Ltd., and Kuehne + Nagel.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The pharmaceutical drugs and biologics logistics market is segmented in four ways: by type of service, mode of transport, pharmaceutical type and therapeutic area.
Type of Service includes cold chain logistics and non cold chain logistics.
Mode of Transport includes air transportation, ocean transportation, and land transportation.
Pharmaceutical Type includes pharmaceutical drugs logistics and biologics logistics.
Therapeutic Area consists of logistics for drugs and biologics for the treatment of diseases in the following categories: musculoskeletal, cardiovascular, oncology, anti-infective, metabolic disorders, central nervous system, genito-urinary, respiratory, gastro-intestinal, hematology, dermatology, and ophthalmology.